Abstract:Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease characterized by progressive paralysis and ultimately respiratory failure within 5 years of symptom onset. Approximately 5–10% of ALS cases exhibit familial inheritance (FALS) and causative gene mutations can be found in 60% of FALS patients. The remaining 90–95% of ALS cases show sporadic manner (SALS) and mutations in the same genes are responsible for 10% of SALS patients. To date, rare variants in more than 30 genes have been reported to cause or be associated with ALS. Recently, Smith and et al. identified mutations in ANXA11 in ALS patients of European ancestry but pathogenicity of ANXA11 in other ALS cohorts remained unproved. In the current study, we investigated ANXA11 mutations in Chinese ALS patients with or without cognitive decline. A total of 383 Chinese ALS patients were recruited at ALS clinic of Neurology Department, Peking Union Medical College Hospital (PUMCH) from January 2016 to August 2017. All coding exons and at least 100 bp of flanking introns of ANXA11(NM_145869) were sequenced using ABI 3730 automated DNA-sequencing system. Rare variants (MAF < 0.1%) with high conservation were further assessed for pathogenicity using online prediction software including SIFT, PolyPhen2 and Mutation taster. ESEfinder 3.0 and Human Splicing Finder 3.0 were applied to predict the effect of mutation on mRNA splicing. Total RNA was extracted using TRIzol (Invitrogen) from peripheral white blood cells. Then 2.5 μg RNA were used to perform Reverse transcriptase-PCR. cDNA was amplified using primer pair ANXA11-RT-F(5′-CCATGAGCTACCCTGGCTAT-3′) and ANXA11-RT-R(5′-GACTCCCCAGGCAGTCAAT-3′) locating at ANXA11 exon 4 and exon 8 (shown in Fig. 3), respectively. The PCR products were isolated on a 1.5% agarose gel. DNA fragments of interest were gel-purified and sequenced. We identified 6 nonsynonymous heterozygous mutations (c.107C>G, p.P36R; c.119A>G, p.D40G; c.382G>A, p.V128M; c.687T>A, p.S229R; c.904C>T, p.R302C; c.1471G>A, p.G491R) and 1 splice-site mutation(c.174-2A>G, p.A58_Q187del) in 10 unrelated patients, accounting for a mutant frequency of 5.6% (1/18) in FALS, 2.3% (8/353) in SALS and 8.3% (1/12) in ALS-FTD. A novel p. P36R mutation was identified in one FALS index, one SALS patient and one ALS-FTD. The splicing mutation(c.174-2A>G) caused in-frame skipping of the entire exon 6 and further supported the loss-of-function mechanism. ANXA11 gene is the most frequently mutated genes in Chinese patients with SALS. The study findings further expand the ANXA11 phenotype, firstly highlighting its pathogenic role in ALS-FTD.

Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

Novel and Recurrent Mutations in a Cohort of Chinese Patients with Young-Onset Amyotrophic Lateral Sclerosis

Whole-exome Sequencing in Amyotrophic Lateral Sclerosis Suggests NEK1 is a Risk Gene in Chinese

Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients

Genetic Analysis of and Clinical Characteristics Associated with ANXA11 Variants in a Chinese Cohort with Amyotrophic Lateral Sclerosis

Rare, Low-Frequency and Common Coding Variants of ARHGEF28 Gene and Their Association with Sporadic Amyotrophic Lateral Sclerosis.

Whole Exome Sequencing of Familial ALS and Trios of Sporadic ALS to Identify New Genes Associated with ALS (P5.047)

Role of Genetics in Amyotrophic Lateral Sclerosis: a Large Cohort Study in Chinese Mainland Population.

Two Rare Variants of the ANXA11 Gene Identified in Chinese Patients with Amyotrophic Lateral Sclerosis.

Clinical and genetic characteristics of 1672 cases of amyotrophic lateral sclerosis in China: a single-center retrospective study

Recent advances in the genetics of familial and sporadic ALS

Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis

ANXA11 Mutations Prevail in Chinese Amyotrophic Lateral Sclerosis Patients with and Without Cognitive Dementia (P1.320)

Amyotrophic Lateral Sclerosis Genetic Studies

Clinical and Genetic Features of Patients with Amyotrophic Lateral Sclerosis in Southern China.

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS

S55. ANXA11 Mutations Prevail in Chinese ALS Patients with and Without Cognitive Dementia

Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations

Dctn1 Gene Analysis In Chinese Patients With Sporadic Amyotrophic Lateral Sclerosis